David A Hall1, Jesús Giraldo2,3. 1. Fibrosis and Lung Injury DPU, GlaxoSmithKline, Stevenage, UK. 2. Laboratory of Molecular Neuropharmacology and Bioinformatics, Institut de Neurociències and Unitat de Bioestadística, Universitat Autònoma de Barcelona, Bellaterra, Spain. 3. Network Biomedical Research Center on Mental Health (CIBERSAM), Bellaterra, Spain.
Abstract
BACKGROUND AND PURPOSE: Biased agonism, the ability of an agonist to differentially activate one of several signal transduction pathways when acting at a given receptor, is an increasingly recognized phenomenon at many receptors. The Black and Leff operational model lacks a way to describe constitutive receptor activity and hence inverse agonism. Thus, it is impossible to analyse the biased signalling of inverse agonists using this model. In this theoretical work, we develop and illustrate methods for the analysis of biased inverse agonism. EXPERIMENTAL APPROACH: Methods were derived for quantifying biased signalling in systems that demonstrate constitutive activity using the modified operational model proposed by Slack and Hall. The methods were illustrated using Monte Carlo simulations. KEY RESULTS: The Monte Carlo simulations demonstrated that, with an appropriate experimental design, the model parameters are 'identifiable'. The method is consistent with methods based on the measurement of intrinsic relative activity (RAi ) (ΔΔlogR or ΔΔlog(τ/Ka )) proposed by Ehlert and Kenakin and their co-workers but has some advantages. In particular, it allows the quantification of ligand bias independently of 'system bias' removing the requirement to normalize to a standard ligand. CONCLUSIONS AND IMPLICATIONS: In systems with constitutive activity, the Slack and Hall model provides methods for quantifying the absolute bias of agonists and inverse agonists. This provides an alternative to methods based on RAi and is complementary to the ΔΔlog(τ/Ka ) method of Kenakin et al. in systems where use of that method is inappropriate due to the presence of constitutive activity.
BACKGROUND AND PURPOSE: Biased agonism, the ability of an agonist to differentially activate one of several signal transduction pathways when acting at a given receptor, is an increasingly recognized phenomenon at many receptors. The Black and Leff operational model lacks a way to describe constitutive receptor activity and hence inverse agonism. Thus, it is impossible to analyse the biased signalling of inverse agonists using this model. In this theoretical work, we develop and illustrate methods for the analysis of biased inverse agonism. EXPERIMENTAL APPROACH: Methods were derived for quantifying biased signalling in systems that demonstrate constitutive activity using the modified operational model proposed by Slack and Hall. The methods were illustrated using Monte Carlo simulations. KEY RESULTS: The Monte Carlo simulations demonstrated that, with an appropriate experimental design, the model parameters are 'identifiable'. The method is consistent with methods based on the measurement of intrinsic relative activity (RAi ) (ΔΔlogR or ΔΔlog(τ/Ka )) proposed by Ehlert and Kenakin and their co-workers but has some advantages. In particular, it allows the quantification of ligand bias independently of 'system bias' removing the requirement to normalize to a standard ligand. CONCLUSIONS AND IMPLICATIONS: In systems with constitutive activity, the Slack and Hall model provides methods for quantifying the absolute bias of agonists and inverse agonists. This provides an alternative to methods based on RAi and is complementary to the ΔΔlog(τ/Ka ) method of Kenakin et al. in systems where use of that method is inappropriate due to the presence of constitutive activity.
Authors: Aashish Manglik; Henry Lin; Dipendra K Aryal; John D McCorvy; Daniela Dengler; Gregory Corder; Anat Levit; Ralf C Kling; Viachaslau Bernat; Harald Hübner; Xi-Ping Huang; Maria F Sassano; Patrick M Giguère; Stefan Löber; Grégory Scherrer; Brian K Kobilka; Peter Gmeiner; Bryan L Roth; Brian K Shoichet Journal: Nature Date: 2016-08-17 Impact factor: 49.962
Authors: Scott M DeWire; Dennis S Yamashita; David H Rominger; Guodong Liu; Conrad L Cowan; Thomas M Graczyk; Xiao-Tao Chen; Philip M Pitis; Dimitar Gotchev; Catherine Yuan; Michael Koblish; Michael W Lark; Jonathan D Violin Journal: J Pharmacol Exp Ther Date: 2013-01-08 Impact factor: 4.030
Authors: Javier Burgueño; Marta Pujol; Xavier Monroy; David Roche; Maria Jose Varela; Manuel Merlos; Jesús Giraldo Journal: Sci Rep Date: 2017-11-13 Impact factor: 4.379